Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study

MLA

Ron Bose, et al. “Targeted Therapy for Advanced Solid Tumors Based on Molecular Profiles: Early Results from MyPathway, an Open-Label, Phase IIa Umbrella Basket Study.” Journal of Clinical Oncology, vol. 34, May 2016, p. LBA11511. EBSCOhost, https://doi.org/10.1200/jco.2016.34.15_suppl.lba11511.

APA

Ron Bose, David R. Spigel, Coen Bernaards, Mary Beattie, Razelle Kurzrock, Herbert Hurwitz, Funda Meric-Bernstam, Howard A. Burris, Christopher Sweeney, John D. Hainsworth, Charles Swanton, Shuangli Guo, Alisha Stein, & Melissa Brammer. (2016). Targeted therapy for advanced solid tumors based on molecular profiles: Early results from MyPathway, an open-label, phase IIa umbrella basket study. Journal of Clinical Oncology, 34, LBA11511. https://doi.org/10.1200/jco.2016.34.15_suppl.lba11511

Chicago

Ron Bose, David R. Spigel, Coen Bernaards, Mary Beattie, Razelle Kurzrock, Herbert Hurwitz, Funda Meric-Bernstam, et al. 2016. “Targeted Therapy for Advanced Solid Tumors Based on Molecular Profiles: Early Results from MyPathway, an Open-Label, Phase IIa Umbrella Basket Study.” Journal of Clinical Oncology 34 (May): LBA11511. doi:10.1200/jco.2016.34.15_suppl.lba11511.